Company / Operating Income
Biohaven Ltd. Operating Income History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$885.1M
FY2024
5-year range
-$885.1M / -$114.5M
FY2020-FY2024
Trend
-103.0%
vs FY2023
Sector context
#197 of 204
Health Care
What the data says
Among 204 Health Care companies, Biohaven Ltd. is in the bottom 3% for operating income. Declined from -$568M to -$885M over the past 2 years.
Based on SEC 10-K filings.
-$885M in FY2024.
Declined from -$568M to -$885M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 204This company -$885.1M Sector average $107.8M
▼
-921.4% below sector average
Key checks
Key Insights
- In FY2024, operating income decreased 103.0% year-over-year.
- Ranks #197 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.10 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$885.1M | -103.0% |
| FY2023 | -$436.1M | +23.2% |
| FY2022 | -$567.9M | -159.4% |
| FY2021 | -$218.9M | -91.2% |
| FY2020 | -$114.5M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026